Transcriptional and translational regulation of C/EBP β-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1 α proteins at the early and late stages of liver cancer

Journal of Biological Chemistry

Volumn 288, Issue 20, 2013, Pages 14451-14462

  Jin, Gling ^a   Iakova, Polina ^a   Jiang, Yanjun ^a   Lewis, Kyle ^a   Sullivan, Emily ^a   Jawanmardi, Nicole ^a   Donehower, Lawrence ^a   Timchenko, Lubov ^a   Timchenko, Nikolai A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT/ENHANCER-BINDING PROTEINS; DIETHYLNITROSAMINE; ENHANCER BINDING PROTEINS; HISTONE DEACETYLASES; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN MODIFICATIONS; RNA-BINDING PROTEIN; TRANSLATIONAL REGULATION;

CHEMICAL ACTIVATION; DISEASES; RNA; TRANSCRIPTION;

PROTEINS;

CCAAT ENHANCER BINDING PROTEIN BETA; DIETHYLNITROSAMINE; HISTONE DEACETYLASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN CUGBP1; PROTEIN P53; RNA BINDING PROTEIN; SIRTUIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ISOLATION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; WESTERN BLOTTING;

C/EBP; CANCER; CANCER TUMOR PROMOTER; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION (CHIP); CYCLIN-DEPENDENT KINASE (CDK); EPIGENETIC; LIVER; TRANSLATION;

ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL PROLIFERATION; DIETHYLNITROSAMINE; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HISTONE DEACETYLASE 1; HUMANS; LIVER NEOPLASMS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; SIRTUIN 1; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877906179     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.460840     Document Type: Article

References (24)

1. Liu, W. R., Shi, Y. H., Peng, Y. F., and Fan, J. (2012) Epigenetics of hepatocellular carcinoma. A new horizon. Chin. Med. J. 125, 2349-2360
2. Nishida, N., and Goel, A. (2011) Genetic and epigenetic signatures in human hepatocellular carcinoma. A systematic review. Curr. Genomics. 12, 130-137
3. Mandrekar, P. (2011) Epigenetic regulation in alcoholic liver disease. World J. Gastroenterol. 17, 2456-2464
4. Wang, G. L., Salisbury, E., Shi, X., Timchenko, L., Medrano, E. E., and Timchenko, N. A. (2008) HDAC1 promotes liver proliferation in young mice via interactions with C/EBPβ. J. Biol. Chem. 283, 26179-26187
5. Wang, Y., and Lee, C. G. (2011) Role of miR-224 in hepatocellular carcinoma. A tool for possible therapeutic intervention? Epigenomics 3, 235-243
6. Buurman, R., Gürlevik, E., Schäffer, V., Eilers, M., Sandbothe, M., Kreipe, H., Wilkens, L., Schlegelberger, B., Kühnel, F., and Skawran, B. (2012) Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143, 811-820
7. Xie, H. J., Noh, J. H., Kim, J. K., Jung, K. H., Eun, J. W., Bae, H. J., Kim, M. G., Chang, Y. G., Lee, J. Y., Park, H., and Nam, S. W. (2012) HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer. PLoS ONE 7, e34265
8. Jones, K., Timchenko, L., and Timchenko, N. A. (2012) The role of CUGBP1 in age-dependent changes of liver functions. Ageing Res. Rev. 11, 442-449
9. Wang, G. L., Salisbury, E., Shi, X., Timchenko, L., Medrano, E. E., and Timchenko, N. A. (2008) HDAC1 cooperates with C/EBPα in the inhibition of liver proliferation in old mice. J. Biol. Chem. 283, 26169-26178
10. Iakova, P., Awad, S. S., and Timchenko, N. A. (2003) Aging reduces proliferative capacities of liver by switching pathways of C/EBPα growth arrest. Cell 113, 495-506 (Pubitemid 36588752)
11. Jin, J., Wang, G. L., Iakova, P., Shi, X., Haefliger, S., Finegold, M., and Timchenko, N. A. (2010) Epigenetic changes play critical role in age-associated dysfunctions of the liver. Aging Cell 9, 895-910
12. Jin, J., Wang, G. L., Shi, X., Darlington, G. J., and Timchenko, N. A. (2009) The age-associated decline of glycogen synthase kinase 3 β plays a critical role in the inhibition of liver regeneration. Mol. Cell. Biol. 29, 3867-3880
13. Jin, J., Iakova, P., Jiang, Y., Medrano, E. E., and Timchenko, N. A. (2011) The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation. Hepatology 54, 989-998
14. Timchenko, L. T., Salisbury, E., Wang, G. L., Nguyen, H., Albrecht, J. H., Hershey, J. W., and Timchenko, N. A. (2006) Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein β in old liver. J. Biol. Chem. 281, 32806-32819 (Pubitemid 46036836)
15. Wang, G. L., Shi, X., Haefliger, S., Jin, J., Major, A., Iakova, P., Finegold, M., and Timchenko, N. A. (2010) Elimination of C/EBPα through the ubiquitin-proteasome system promotes the development of liver cancer in mice. J. Clin. Invest. 120, 2549-2562
16. Jiang, Y., Iakova, P., Jin, J., Sullivan, E., Sharin, V., Hong, I. H., Anakk, S., Mayor, A., Darlington, G., Finegold, M., Moore, D., and Timchenko, N. A. (2013) FXR inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 57, 1098-1106
17. Boggs, K., and Reisman, D. (2007) C/EBPβ participates in regulating transcription of the p53 gene in response to mitogen stimulation. J. Biol. Chem. 282, 7982-7990 (Pubitemid 47093547)
18. Ewing, S. J., Zhu, S., Zhu, F., House, J. S., and Smart, R. C. (2008) C/EBPβ represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death Differ. 15, 1734-1744
19. Di Stefano, L., Jensen, M. R., and Helin, K. (2003) E2F7, a novel E2F featuring DP-independent repressor of subset of E2F-regulated genes. EMBO J. 22, 6289-6298 (Pubitemid 37522586)
20. Carvajal, L. A., Hamard, P. J., Tonnessen, C., and Manfredi, J. J. (2012) E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Genes Dev. 26, 1533-1545
21. Thomas, A. M., Hart, S. N., Kong, B., Fang, J., Zhong, X. B., and Guo, G. L. (2010) Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology 51, 1410-1419
22. Jin, J., Iakova, P., Breaux, M., Sullivan, E., Jawanmardi, N., Chen, D., Jiang, Y., Medrano, E. M., and Timchenko, N. A. (2013) Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. Cell Rep. 3, 831-843
23. 1/S cell cycle check point and induction of apoptosis. Carcinogenesis 33, 2424-2431
24. Slee, E. A., Benassi, B., Goldin, R., Zhong, S., Ratnayaka, I., Blandino, G., and Lu, X. Proc. (2010) Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo. Natl. Acad. Sci. U.S.A. 107, 19479-19484